Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977; 70(Suppl 10): 15–19.
PMCID: PMC1542813

The Role of Dopamine in the Antipsychotic Effect and the Pathogenesis of Schizophrenia

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (838K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Angrist B, Lee HK, Gershon S. The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am J Psychiatry. 1974 Jul;131(7):817–819. [PubMed]
  • Bennett JP, Jr, snyder SH. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors. Brain Res. 1975 Sep 5;94(3):523–544. [PubMed]
  • CASEY JF, BENNETT IF, LINDLEY CJ, HOLLISTER LE, GORDON MH, SPRINGER NN. Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo. AMA Arch Gen Psychiatry. 1960 Feb;2:210–220. [PubMed]
  • Crow TJ, Deakin JF, Longden A. The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs? Psychol Med. 1977 May;7(2):213–221. [PubMed]
  • Crow TJ, Frith C, Johnstone EC. The clinical effects of the isomers of flupenthixol--the consequences of dopamine receptor blockade in acute schizophrenia [proceedings]. Br J Clin Pharmacol. 1977 Oct;4(5):648P–648P. [PubMed]
  • Crow TJ, Johnstone EC, McClelleand HA. The coincidence of schizophrenia and Parkinsonism: some neurochemical implications. Psychol Med. 1976 May;6(2):227–233. [PubMed]
  • Enna SJ, Bennett JP, Jr, Burt DR, Creese I, Snyder SH. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency. Nature. 1976 Sep 23;263(5575):338–341. [PubMed]
  • Griffith JD, Cavanaugh J, Held J, Oates JA. Dextroamphetamine. Evaluation of psychomimetic properties in man. Arch Gen Psychiatry. 1972 Feb;26(2):97–100. [PubMed]
  • Horn AS, Snyder SH. Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2325–2328. [PubMed]
  • Johnstone EC, Crow TJ, Mashiter K. Anterior pituitary hormone secretion in chronic schizophrenia--an approach to neurohumoral mechanisms. Psychol Med. 1977 May;7(2):223–228. [PubMed]
  • Meltzer HY, Sachar EJ, Frantz AG. Serum prolactin levels in unmedicated schizophrenic patients. Arch Gen Psychiatry. 1974 Oct;31(4):564–569. [PubMed]
  • Miller RJ, Hiley CR. Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism. Nature. 1974 Apr 12;248(449):596–597. [PubMed]
  • Randrup A, Munkvad I. Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities. Psychopharmacologia. 1965 May 21;7(6):416–422. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press